FDA issues advisory on prostate cancer drugs

[News]

Gonadotropin-Releasing Hormone (GnRH) agonists, a class of medications primarily used to treat men with prostate cancer, have been associated with a small increased risk for diabetes, heart attack, stroke, and sudden death in men treated with one of the medications, according to a preliminary and ongoing analysis of several studies by the U.S. Food and Drug Administration.

More... (http://www.news-medical.net/news/20100503/FDA-issues-advisory-on-prostate-cancer-drugs.aspx)